{
  "paper_metadata": {
    "pmid": "27033334",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses various TTR variants associated with ATTR amyloidosis, focusing on the Val30Met variant and its implications for disease penetrance and treatment strategies."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.148G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "ATTR amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "ATTR amyloidosis",
          "evidence_sentence": "hTTR V30M HSF1\u00b1 transgenic mice were administered a single injection of siTTR1, siTTR2 or their respective controls and evaluated for liver TTR mRNA and serum TTR protein knockdown."
        }
      ],
      "functional_data": {
        "summary": "In vitro analysis showed that siTTR silenced wt and mutant TTR gene constructs with similar efficacy and potency.",
        "assays": [
          "Dual-Luciferase reporter assay",
          "serum TTR protein measurement"
        ]
      },
      "segregation_data": "The phenotype is fully penetrant in mice older than 12 months of age.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study emphasizes the importance of TTR lowering in the treatment of ATTR amyloidosis.",
      "key_quotes": [
        "The phenotype is fully penetrant in mice older than 12 months of age and is therefore a good model for evaluating the therapeutic hypothesis of TTR lowering in ATTR amyloidosis."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper focused on TTR variants and their implications."
  }
}